KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Cash from Investing Activities (2020 - 2025)

AbCellera Biologics' Cash from Investing Activities history spans 6 years, with the latest figure at $75.1 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities rose 110.45% year-over-year to $75.1 million, compared with a TTM value of $87.8 million through Dec 2025, down 27.72%, and an annual FY2025 reading of $87.8 million, down 27.72% over the prior year.
  • Cash from Investing Activities for Q4 2025 was $75.1 million at AbCellera Biologics, up from $36.5 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $75.1 million in Q4 2025, with the low at -$282.0 million in Q3 2022.
  • Average Cash from Investing Activities over 5 years is -$34.8 million, with a median of -$16.5 million recorded in 2021.
  • Year-over-year, Cash from Investing Activities tumbled 6840.18% in 2021 and then surged 886.7% in 2025.
  • Tracing ABCL's Cash from Investing Activities over 5 years: stood at -$1.1 million in 2021, then crashed by 1385.03% to -$17.1 million in 2022, then plummeted by 42.55% to -$24.3 million in 2023, then surged by 246.79% to $35.7 million in 2024, then soared by 110.45% to $75.1 million in 2025.
  • Per Business Quant, the three most recent readings for ABCL's Cash from Investing Activities are $75.1 million (Q4 2025), $36.5 million (Q3 2025), and -$31.8 million (Q2 2025).